CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $82,000 | +2.5% | 3,315 | -25.4% | 0.00% | -50.0% |
| Q4 2018 | $80,000 | -40.7% | 4,443 | -3.0% | 0.00% | 0.0% |
| Q3 2018 | $135,000 | -38.1% | 4,582 | -4.5% | 0.00% | -50.0% |
| Q2 2018 | $218,000 | -25.9% | 4,797 | -5.4% | 0.00% | -20.0% |
| Q1 2018 | $294,000 | -16.0% | 5,071 | -1.3% | 0.01% | -16.7% |
| Q4 2017 | $350,000 | -18.8% | 5,140 | -1.7% | 0.01% | -14.3% |
| Q3 2017 | $431,000 | +143.5% | 5,229 | +175.9% | 0.01% | +133.3% |
| Q2 2017 | $177,000 | +284.8% | 1,895 | +160.7% | 0.00% | +200.0% |
| Q1 2017 | $46,000 | – | 727 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |